The FDA will decide this summer which strains the next Covid-19 vaccines should address. But companies are also taking a longer view, developing shots for the future that offer different features than the current ones and potentially broader protection against a wider range of pathogens.
Mae’s services will be a covered benefit for Aetna Better Health Medicaid members through a new pilot program. These services include access to a culturally-competent doula and an engagement platform that provides weekly check-ins and tools to support maternal health.
Eli Lilly is selling to Amphastar Pharmaceuticals global rights to Baqsimi, an emergency treatment for severe hypoglycemia in diabetes patients. The deal come as Lilly turns its focus to novel medicines for diabetes and other indications.
A clinical trial for a Foghorn Therapeutics cancer drug is under a partial FDA hold after a patient in the early-stage study developed a cardiovascular complication. It’s the biotech’s second partial hold in the past year.
Eden Health will join Hint Health’s Hint Connect platform, which is a network of independent direct primary care clinics. Through the partnership, employees of Hint Connect’s employer customers will be able to choose whether they want to receive care from a local DPC provider in their area (either in-person or virtually) or a virtual provider through Eden Health.